Cipher Pharmaceuticals, Inc. (CPH.TO)
14.16
+0.06
(+0.43%)
CAD |
TSX |
Aug 25, 16:00
Cipher Pharmaceuticals Shareholders Equity (Quarterly) : 194.73M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 194.73M |
| March 31, 2026 | 185.25M |
| December 31, 2025 | 173.05M |
| September 30, 2025 | 158.53M |
| June 30, 2025 | 149.33M |
| March 31, 2025 | 151.47M |
| December 31, 2024 | 147.19M |
| September 30, 2024 | 133.55M |
| June 30, 2024 | 121.50M |
| March 31, 2024 | 115.83M |
| December 31, 2023 | 106.17M |
| September 30, 2023 | 104.84M |
| June 30, 2023 | 92.89M |
| March 31, 2023 | 90.87M |
| December 31, 2022 | 86.83M |
| September 30, 2022 | 61.07M |
| June 30, 2022 | 54.07M |
| March 31, 2022 | 50.40M |
| December 31, 2021 | 49.13M |
| September 30, 2021 | 46.68M |
| June 30, 2021 | 45.03M |
| March 31, 2021 | 42.64M |
| December 31, 2020 | 41.59M |
| September 30, 2020 | 43.82M |
| June 30, 2020 | 42.45M |
| Date | Value |
|---|---|
| March 31, 2020 | 43.71M |
| December 31, 2019 | 36.32M |
| September 30, 2019 | 32.91M |
| June 30, 2019 | 35.40M |
| March 31, 2019 | 34.25M |
| December 31, 2018 | 33.82M |
| September 30, 2018 | 33.12M |
| June 30, 2018 | 32.47M |
| March 31, 2018 | 28.73M |
| December 31, 2017 | 29.20M |
| September 30, 2017 | 23.81M |
| June 30, 2017 | 20.89M |
| March 31, 2017 | 20.28M |
| December 31, 2016 | 24.16M |
| September 30, 2016 | 38.63M |
| June 30, 2016 | 65.05M |
| March 31, 2016 | 67.99M |
| December 31, 2015 | 75.37M |
| September 30, 2015 | 69.18M |
| June 30, 2015 | 66.06M |
| March 31, 2015 | 84.81M |
| December 31, 2014 | 62.74M |
| September 30, 2014 | 58.50M |
| June 30, 2014 | 48.74M |
| March 31, 2014 | 43.14M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| HLS Therapeutics, Inc. | 78.37M |
| Bausch Health Cos., Inc. | -2.513B |
| BioSyent, Inc. | 45.84M |
| Revive Therapeutics Ltd. | -4.025M |
| Knight Therapeutics, Inc. | 798.59M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 222.59M |
| Total Liabilities (Quarterly) | 27.86M |
| Debt to Equity Ratio | 0.0027 |
| Current Ratio | 1.588 |
| Net Debt Paydown Yield | 2.73% |